ACLA

Aclara Biosciences (ACLA)

Aclara Biosciences, (MM)

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ACLA

일자	시간	출처	헤드라인	심볼	기업
2004/12/11	03:31	PR Newswire (US)	ViroLogic and ACLARA Announce Stockholder Approval of Merger	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/12/02	23:00	PR Newswire (US)	Iceland Genomics Corporation and ACLARA Collaborating on Cancer Biomarkers	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/11/09	21:45	PR Newswire (US)	ACLARA Announces Third Quarter 2004 Financial Results	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/11/08	21:00	PR Newswire (US)	ViroLogic and ACLARA to Mail Revised Definitive Proxy for Proposed Merger	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/11/04	21:45	PR Newswire (US)	Clinical Data Presented at ESMO Shows ETAG(TM) System's Potential in Predicting Response to Cancer Treatment	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/10/27	22:01	PR Newswire (US)	Manuel Hidalgo, M.D., Ph.D., Joins ACLARA BioSciences Scientific Advisory Board	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/10/19	21:00	PR Newswire (US)	ViroLogic and ACLARA BioSciences Revise Merger Terms	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/10/05	21:45	PR Newswire (US)	ACLARA and GlaxoSmithKline Evaluating eTag(TM) Technology for Patient Selection for Targeted Cancer Therapies	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/09/30	21:45	PR Newswire (US)	ACLARA Data at EORTC-NCI-AACR Symposium Demonstrates ETAG(TM) System Potential in Cancer Drug Development and Treatment Prognosi	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/09/29	07:04	PR Newswire (US)	ViroLogic and ACLARA Mail Definitive Proxy for Proposed Merger	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/08/05	06:30	PR Newswire (US)	Aclara Announces Second Quarter Financial Results	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/07/07	21:00	PR Newswire (US)	ACLARA BioSciences Appoints Roy S. Herbst, M.D., Ph.D., To Scientific Advisory Board	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/06/14	21:45	PR Newswire (US)	ACLARA BioSciences and Tokyo Metropolitan Institute of Medical Science (Rinshoken) to Conduct Breast Cancer Biomarker Study	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/06/11	09:11	PR Newswire (US)	Aclara to Present at Needham Third Annual Biotechnology Conference	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/06/10	21:45	PR Newswire (US)	Prominent Oncologist Appointed to ACLARA Scientific Advisory Board	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/06/03	22:00	PR Newswire (US)	ACLARA to Host Investor Briefing and Webcast at ASCO Annual Meeting Monday June 7, 2004 at 7:00 A.M. Central time	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/06/03	06:20	PR Newswire (US)	ACLARA eTag Technology to be Discussed at ASCO Annual Meeting	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/06/01	21:30	PR Newswire (US)	ViroLogic and ACLARA BioSciences Announce Merger	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/04/29	22:30	PR Newswire (US)	ACLARA Announces First Quarter Financial Results	NASDAQ:ACLA	Aclara Biosciences, (MM)
2004/04/05	22:30	PR Newswire (US)	ACLARA Receives Four U.S. Patents for Its eTag(TM) and Nanofluidic Technologies	NASDAQ:ACLA	Aclara Biosciences, (MM)
2003/12/11	22:00	PR Newswire (US)	John Weinstein, M.D. Ph.D. Appointed to ACLARA Scientific Advisory Board	NASDAQ:ACLA	Aclara Biosciences, (MM)
2003/12/04	22:30	PR Newswire (US)	ACLARA and Cell Signaling Technology, Inc. Enter into Antibody Supply Agreement	NASDAQ:ACLA	Aclara Biosciences, (MM)
2003/11/06	06:00	PR Newswire (US)	ACLARA Announces Third Quarter 2003 Financial Results	NASDAQ:ACLA	Aclara Biosciences, (MM)
2003/10/30	04:00	PR Newswire (US)	ADVISORY: ACLARA BioSciences, Inc. to Announce Q3 2003 Financial Results On November 5, 2003	NASDAQ:ACLA	Aclara Biosciences, (MM)